Uninechol Tablet (Bethanechol Chloride)

Adult dose

Adults: Administer 10 ~ 25 milligrams per dose, 3 ~ 4 times daily. Taking this medicine immediately after a meal may cause symptoms such as nausea and vomiting; therefore, taking it on an empty stomach is recommended.

If serious side effects occur after using this drug, immediate treatment with subcutaneous atropine sulfate injection should be administered. This drug should not be used in patients with mechanical obstruction of the gastrointestinal tract or urinary tract. Patients with spastic gastrointestinal disease, gastric ulcer, or acute inflammatory bowel disease should not take this drug. It should also not be administered to patients with peritonitis or increased vagal tone. Patients with asthma or hyperthyroidism should avoid this drug. The drug is not used in cases of coronary artery occlusion, bradycardia, atrioventricular block, or vasomotor instability. Patients with low blood pressure or high blood pressure should be cautious, and those with myocardial infarction or severe heart disease should not receive this medication. Patients with seizures or symptoms of Parkinson's disease should also refrain from using this drug. Patients taking cholinesterase inhibitors should not combine this drug with them. Patients who are not healed after gastrointestinal anastomosis or pregnant women should also not take this drug. Additionally, since this drug contains lactose, it should not be given to patients with genetic problems such as lactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. Side effects such as heartburn, abdominal discomfort, nausea, vomiting, gastric cramps, and diarrhea may occur when taking this drug. There may also be neurological symptoms such as sweating, flushing, and increased salivation. Cardiovascular side effects such as palpitations or hypotension may be experienced, and atrial fibrillation may temporarily occur in patients with hypertension. In cases of overdose, one should be cautious of loss of consciousness due to cardiac arrest, complete heart block, respiratory distress, orthostatic hypotension, involuntary bowel movements, and sudden urgency to urinate. Asthma patients may experience asthma attacks, chest tightness, headaches, and discomfort. This drug may reduce cholinergic effects when taken with quinidine or procainamide, so caution is necessary. When combined with cholinergic drugs, especially cholinesterase inhibitors, effects may be enhanced, so caution should be exercised. Administration to patients taking sympatholytics may result in severe abdominal symptoms and rapid blood pressure drop, requiring special consideration.

• heartburn
• abdominal discomfort
• nausea
• vomiting
• gastric cramps
• diarrhea
• sweating
• flush
• salivation
• palpitations

This medication should be stored in a tightly sealed container to protect it from air and moisture exposure. It is advisable to maintain the storage temperature in a range between 1 degree and 30 degrees Celsius. This will help preserve the efficacy of the medication for a longer period.

Appearance

Yellow round tablets

Package unit

100 tablets/bottle, 300 tablets/bottle